ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
With the opening of a new facility in Queenborough, England, the drug services firm Aesica Pharmaceuticals says it has doubled its drug product development capacity. Aesica says the capabilities in the new facility allow it to develop and manufacture a customer’s product from early formulation development through clinical trials and into commercialization. The Queenborough site can handle both highly potent and controlled substances, the company adds.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X